Brief: Sedana Medical Q1 EBITDA Loss Widens To SEK 2.6 Million

Sedana Medical AB (publ)

08/05/2019 06:07

May 8 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * , INTERIM REPORT Q1, 2019
    * Q1 NET SALES SEK 17.8 MILLION VERSUS SEK 15.5 MILLION YEAR
AGO
    * Q1 EBITDA LOSS SEK 2.6 MILLION VERSUS LOSS SEK 788,000
YEAR AGO
    * Q1 OF 2019 HAS BEEN OUR MOST SUCCESSFUL SO FAR REGARDING
OUR
CLINICAL AND REGULATORY DEVELOPMENT - CEO

Source text for Eikon:  ID:nWkr5vN4DP 
Further company coverage:  SEDANA.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))